Aerie Em

01/09/2020

IVI to lead critical standard reagents availability for oral cholera vaccine manufacturing to ensure their uniform efficacy and help meet global demand

  January 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) received a $1.4 million grant from the Bill & Melinda Gates Foundation to ensure critical standards and reagents are available to low-cost oral cholera vaccine (OCV) manufacturers in the global health […]
12/19/2019

KSC holds donation ceremony for IVI to recognize major donors

On December 19, 2019, the Korea Support Committee (KSC) held a donation ceremony to present IVI with a total donation of 423M Korean won (> 365,000 USD) made possible by generous donors across industry, academia, health organizations, and individuals. Major donors and representatives from donating […]
12/18/2019

IVI appoints three new members to its Board of Trustees

December 18, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization dedicated to accelerating vaccines for global health, announced today that Professor Gordon Dougan, Dr. Melanie Saville, and Dr. Jean-Marie Okwo-Bele will join its Board of Trustees (BOT) […]
11/24/2019

World Antibiotic Awareness Week 2019

Accelerate vaccines. Decelerate AMR.   Every November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices to avoid its further emergence and spread. This year, IVI ran a social media campaign to raise awareness specifically around […]